Toric Intraocular Lens Implantation in Pediatric Cataract
- Conditions
- Cataract CongenitalAstigmatismIOL
- Interventions
- Procedure: congenital/pediatric cataract surgeryDevice: Toric IOLsDevice: Non-Toric IOLs
- Registration Number
- NCT06294795
- Lead Sponsor
- Kazakh Eye Research Institute
- Brief Summary
To evaluate the visual and refractive outcomes after an intraocular lens (IOL) implantation in pediatric eyes with cataract and preexisting corneal astigmatism
- Detailed Description
This single-center, single-blinded, prospective, randomized controlled trial was performed at two sites of Kazakh Eye Research Institute.
Children with pediatric cataract and corneal astigmatism were included and randomized to two groups for pediatric cataract surgery with toric and non-toric IOLs implantation. The uncorrected and corrected distance visual acuity, near visual acuity, keratometry data, and residual astigmatism were evaluated.
The purpose of this study is to evaluate the visual and refractive outcomes after a toric IOL implantation in pediatric eyes with cataract and preexisting corneal astigmatism.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 40
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Toric congenital/pediatric cataract surgery A folding hydrophobic acrylic intraocular lens (IOL) AcrySof IQ SN60WF and Clareon SY60WF Toric Toric IOLs A folding hydrophobic acrylic intraocular lens (IOL) AcrySof IQ SN60WF and Clareon SY60WF Non-toric congenital/pediatric cataract surgery A folding hydrophobic acrylic IOLs AcrySof IQ Toric SN6ATx and Clareon Toric CNW0Tx Non-toric Non-Toric IOLs A folding hydrophobic acrylic IOLs AcrySof IQ Toric SN6ATx and Clareon Toric CNW0Tx
- Primary Outcome Measures
Name Time Method Uncorrected (UCDVA) and corrected (CDVA) distance visual acuity recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year) measured using the Lea symbol visual acuity chart or the Early Treatment of Diabetic Retinopathy Study (ETDRS) chart according to the patient\'s age
Uncorrected (UCNVA) and corrected (CNVA) near visual acuity recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year) measured using the Lea symbol visual acuity chart or the ETDRS chart for near according to the patient\'s age
Refraction measurements recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year) obtained with KR-1W Wavefront Analyzer
- Secondary Outcome Measures
Name Time Method Keratometry measurements recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year) obtained with KR-1W Wavefront Analyzer
Trial Locations
- Locations (1)
Kazakh Eye Research Institute
🇰🇿Astana, Kazakhstan